#METABOLOMICS WORKBENCH Carol_Glez_20181221_084352 DATATRACK_ID:1589 STUDY_ID:ST001117 ANALYSIS_ID:AN001815 PROJECT_ID:PR000748
VERSION             	1
CREATED_ON             	December 26, 2018, 12:51 pm
#PROJECT
PR:PROJECT_TITLE                 	A Metabolomic study of hibernating Syrian hamster brain: in search of
PR:PROJECT_TITLE                 	neuroprotective agents
PR:PROJECT_SUMMARY               	hamster brain samples, divided in 3 groups: torpor, arousal, control group were
PR:PROJECT_SUMMARY               	compared via metabolomics analysis
PR:INSTITUTE                     	Universidad CEU San Pablo
PR:LAST_NAME                     	Gonzalez-Riano
PR:FIRST_NAME                    	Carolina
PR:ADDRESS                       	Facultad de Farmacia, Universidad CEU San Pablo, Campus Monteprincipe, Boadilla
PR:ADDRESS                       	del Monte, Boadilla del Monte, Madrid, 28668, Spain
PR:EMAIL                         	car.gonzalez@ceindo.ceu.es
PR:PHONE                         	00 34 91 3724753
#STUDY
ST:STUDY_TITLE                   	A Metabolomic study of hibernating Syrian hamster brain: in search of
ST:STUDY_TITLE                   	neuroprotective agents
ST:STUDY_TYPE                    	Multiplatform non-targeted metabolomics
ST:STUDY_SUMMARY                 	hamster brain samples, divided in 3 groups: torpor, arousal, control group were
ST:STUDY_SUMMARY                 	compared via metabolomics analysis
ST:INSTITUTE                     	Universidad CEU San Pablo
ST:LABORATORY                    	CEMBIO (Centre for Metabolomics and Bioanalysis)
ST:LAST_NAME                     	Gonzalez-Riano
ST:FIRST_NAME                    	Carolina
ST:ADDRESS                       	Facultad de Farmacia, Universidad CEU San Pablo, Campus Monteprincipe, Boadilla
ST:ADDRESS                       	del Monte, Boadilla del Monte, Madrid, 28668, Spain
ST:EMAIL                         	car.gonzalez@ceindo.ceu.es
ST:PHONE                         	00 34 91 3724753
#SUBJECT
SU:SUBJECT_TYPE                  	Mammal
SU:SUBJECT_SPECIES               	Mesocricetus Auratus
SU:TAXONOMY_ID                   	10036
#SUBJECT_SAMPLE_FACTORS:         	SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Additional sample data
SUBJECT_SAMPLE_FACTORS           	-	A1	hibernation:arousal	
SUBJECT_SAMPLE_FACTORS           	-	A3	hibernation:arousal	
SUBJECT_SAMPLE_FACTORS           	-	A6	hibernation:arousal	
SUBJECT_SAMPLE_FACTORS           	-	A10	hibernation:arousal	
SUBJECT_SAMPLE_FACTORS           	-	A11	hibernation:arousal	
SUBJECT_SAMPLE_FACTORS           	-	C1	hibernation:control	
SUBJECT_SAMPLE_FACTORS           	-	C2	hibernation:control	
SUBJECT_SAMPLE_FACTORS           	-	C3	hibernation:control	
SUBJECT_SAMPLE_FACTORS           	-	C4	hibernation:control	
SUBJECT_SAMPLE_FACTORS           	-	C5	hibernation:control	
SUBJECT_SAMPLE_FACTORS           	-	T2	hibernation:torpor	
SUBJECT_SAMPLE_FACTORS           	-	T4	hibernation:torpor	
SUBJECT_SAMPLE_FACTORS           	-	T5	hibernation:torpor	
SUBJECT_SAMPLE_FACTORS           	-	T10	hibernation:torpor	
SUBJECT_SAMPLE_FACTORS           	-	T11	hibernation:torpor	
#COLLECTION
CO:COLLECTION_SUMMARY            	A total of 15 male 3-month-old Syrian hamsters had free access to food and water
CO:COLLECTION_SUMMARY            	and were kept at 23C with an 8:16-h light/dark cycle for a four to six-week
CO:COLLECTION_SUMMARY            	acclimatization period in our animal facility. All animals were euthanized by
CO:COLLECTION_SUMMARY            	decapitation. Brains were then removed and immediately transferred to a
CO:COLLECTION_SUMMARY            	N2(l)-containing recipient to freeze the tissues.
CO:SAMPLE_TYPE                   	Brain
#TREATMENT
TR:TREATMENT_SUMMARY             	the whole right hemisphere (300 mg approx.) was analyzed to decrease possible
TR:TREATMENT_SUMMARY             	biological variability due to the brain region employed. Brain homogenate was
TR:TREATMENT_SUMMARY             	prepared by adding cold (-20°C) methanol:water (1:1, v/v), (1:10
TR:TREATMENT_SUMMARY             	tissue:solvent). Tissue disruption was achieved with TissueLyser LT homogenizer
TR:TREATMENT_SUMMARY             	(Qiagen, Germany) for metabolite extraction. Subsequently, 100 μL of brain
TR:TREATMENT_SUMMARY             	tissue homogenate was vortex-mixed with 320 μL of methanol for 2 min, followed
TR:TREATMENT_SUMMARY             	by the addition of 80 μL of MTBE for the extraction of non-polar compounds.
TR:TREATMENT_SUMMARY             	Then, vials were rapidly capped and placed on a shaker for 1 h at room
TR:TREATMENT_SUMMARY             	temperature. The extracted samples were centrifuged at 4000 g for 20 min at
TR:TREATMENT_SUMMARY             	20°C. For GC-MS analysis, 300 μL of supernatant was evaporated to dryness
TR:TREATMENT_SUMMARY             	(SpeedVac Concentrator System, Thermo Fisher Scientific, Waltham, MA, USA).
TR:TREATMENT_SUMMARY             	Methoxymation was then performed with 20 µL O-methoxyamine hydrochloride (15
TR:TREATMENT_SUMMARY             	mg/mL in pyridine) and vigorously vortex-mixed for 5 min. Vials were then
TR:TREATMENT_SUMMARY             	incubated in darkness at room temperature for 16 hours. For silylation, 20 μL
TR:TREATMENT_SUMMARY             	of BSTFA:TMCS (99:1) was added, vortex-mixed for 5 min, and capped vials were
TR:TREATMENT_SUMMARY             	placed in the oven at 70°C for 1 h. Finally, 100 μL of heptane containing
TR:TREATMENT_SUMMARY             	C18:0 methyl ester (10 ppm) as Internal Standard (IS) was added to each vial
TR:TREATMENT_SUMMARY             	prior to injection. For LC-MS analysis, 90 μL of supernatant was transferred to
TR:TREATMENT_SUMMARY             	an Ultra-High Performance Liquid Chromatography-Mass (UHPLC-MS) chromatography
TR:TREATMENT_SUMMARY             	vial with insert and was directly injected into the system. For CE-MS analysis,
TR:TREATMENT_SUMMARY             	200 μL of initial brain homogenate was centrifuged separately at 16000 g for 30
TR:TREATMENT_SUMMARY             	min at 15°C. 150 μL of supernatant was evaporated to dryness using the
TR:TREATMENT_SUMMARY             	SpeedVac, and re-suspended in 150 μL of 0.2 mM Methionine Sulfone (IS) in 0.1 M
TR:TREATMENT_SUMMARY             	formic acid. Samples were vortex-mixed, sonicated, and then centrifuged at 16000
TR:TREATMENT_SUMMARY             	g for 20 min at 4°C. Finally, 100 μL of supernatant was transferred to a CE-MS
TR:TREATMENT_SUMMARY             	vial for the analysis.
#SAMPLEPREP
SP:SAMPLEPREP_SUMMARY            	the whole right hemisphere (300 mg approx.) was analyzed to decrease possible
SP:SAMPLEPREP_SUMMARY            	biological variability due to the brain region employed. Brain homogenate was
SP:SAMPLEPREP_SUMMARY            	prepared by adding cold (-20°C) methanol:water (1:1, v/v), (1:10
SP:SAMPLEPREP_SUMMARY            	tissue:solvent). Tissue disruption was achieved with TissueLyser LT homogenizer
SP:SAMPLEPREP_SUMMARY            	(Qiagen, Germany) for metabolite extraction. Subsequently, 100 μL of brain
SP:SAMPLEPREP_SUMMARY            	tissue homogenate was vortex-mixed with 320 μL of methanol for 2 min, followed
SP:SAMPLEPREP_SUMMARY            	by the addition of 80 μL of MTBE for the extraction of non-polar compounds.
SP:SAMPLEPREP_SUMMARY            	Then, vials were rapidly capped and placed on a shaker for 1 h at room
SP:SAMPLEPREP_SUMMARY            	temperature. The extracted samples were centrifuged at 4000 g for 20 min at
SP:SAMPLEPREP_SUMMARY            	20°C. For GC-MS analysis, 300 μL of supernatant was evaporated to dryness
SP:SAMPLEPREP_SUMMARY            	(SpeedVac Concentrator System, Thermo Fisher Scientific, Waltham, MA, USA).
SP:SAMPLEPREP_SUMMARY            	Methoxymation was then performed with 20 µL O-methoxyamine hydrochloride (15
SP:SAMPLEPREP_SUMMARY            	mg/mL in pyridine) and vigorously vortex-mixed for 5 min. Vials were then
SP:SAMPLEPREP_SUMMARY            	incubated in darkness at room temperature for 16 hours. For silylation, 20 μL
SP:SAMPLEPREP_SUMMARY            	of BSTFA:TMCS (99:1) was added, vortex-mixed for 5 min, and capped vials were
SP:SAMPLEPREP_SUMMARY            	placed in the oven at 70°C for 1 h. Finally, 100 μL of heptane containing
SP:SAMPLEPREP_SUMMARY            	C18:0 methyl ester (10 ppm) as Internal Standard (IS) was added to each vial
SP:SAMPLEPREP_SUMMARY            	prior to injection. For LC-MS analysis, 90 μL of supernatant was transferred to
SP:SAMPLEPREP_SUMMARY            	an Ultra-High Performance Liquid Chromatography-Mass (UHPLC-MS) chromatography
SP:SAMPLEPREP_SUMMARY            	vial with insert and was directly injected into the system. For CE-MS analysis,
SP:SAMPLEPREP_SUMMARY            	200 μL of initial brain homogenate was centrifuged separately at 16000 g for 30
SP:SAMPLEPREP_SUMMARY            	min at 15°C. 150 μL of supernatant was evaporated to dryness using the
SP:SAMPLEPREP_SUMMARY            	SpeedVac, and re-suspended in 150 μL of 0.2 mM Methionine Sulfone (IS) in 0.1 M
SP:SAMPLEPREP_SUMMARY            	formic acid. Samples were vortex-mixed, sonicated, and then centrifuged at 16000
SP:SAMPLEPREP_SUMMARY            	g for 20 min at 4°C. Finally, 100 μL of supernatant was transferred to a CE-MS
SP:SAMPLEPREP_SUMMARY            	vial for the analysis
#CHROMATOGRAPHY
CH:CHROMATOGRAPHY_TYPE           	CE
CH:INSTRUMENT_NAME               	Agilent 7100 CE
CH:COLUMN_NAME                   	Fused-silica capillary from Agilent Technologies
#ANALYSIS
AN:ANALYSIS_TYPE                 	MS
#MS
MS:MS_COMMENTS                   	-
MS:INSTRUMENT_NAME               	Agilent 6224 TOF
MS:INSTRUMENT_TYPE               	TOF
MS:MS_TYPE                       	ESI
MS:ION_MODE                      	POSITIVE
MS:MS_RESULTS_FILE               	ST001117_AN001815_Results.txt	UNITS:peak area	Has m/z:Yes	Has RT:Yes	RT units:Minutes
#END